Suvi Parviainen

780 total citations
20 papers, 594 citations indexed

About

Suvi Parviainen is a scholar working on Genetics, Oncology and Biotechnology. According to data from OpenAlex, Suvi Parviainen has authored 20 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 14 papers in Oncology and 7 papers in Biotechnology. Recurrent topics in Suvi Parviainen's work include Virus-based gene therapy research (18 papers), CAR-T cell therapy research (14 papers) and Cancer Research and Treatments (7 papers). Suvi Parviainen is often cited by papers focused on Virus-based gene therapy research (18 papers), CAR-T cell therapy research (14 papers) and Cancer Research and Treatments (7 papers). Suvi Parviainen collaborates with scholars based in Finland, United States and United Kingdom. Suvi Parviainen's co-authors include Akseli Hemminki, Vincenzo Cerullo, Markus Vähä‐Koskela, Iulia Diaconu, Mari Hirvinen, Simona Bramante, Anna Kanerva, Anna Kanerva, Siri Tähtinen and Mikko Siurala and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Suvi Parviainen

19 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suvi Parviainen Finland 13 478 436 223 160 118 20 594
Naomi De Silva Canada 8 431 0.9× 357 0.8× 198 0.9× 122 0.8× 110 0.9× 10 520
Shyambabu Chaurasiya United States 18 414 0.9× 406 0.9× 203 0.9× 128 0.8× 124 1.1× 33 636
Margaret R. Duffy United Kingdom 14 500 1.0× 445 1.0× 386 1.7× 134 0.8× 83 0.7× 25 705
Mari Hirvinen Finland 13 651 1.4× 550 1.3× 361 1.6× 236 1.5× 196 1.7× 19 878
Candice Willmon United States 11 566 1.2× 409 0.9× 272 1.2× 132 0.8× 133 1.1× 17 683
Weizhou Hou United States 9 278 0.6× 315 0.7× 168 0.8× 144 0.9× 61 0.5× 13 453
Sari Pesonen Finland 16 734 1.5× 629 1.4× 448 2.0× 213 1.3× 206 1.7× 24 947
Minna Oksanen Finland 17 726 1.5× 666 1.5× 367 1.6× 210 1.3× 187 1.6× 24 884
Timo Joensuu Finland 18 716 1.5× 668 1.5× 367 1.6× 190 1.2× 176 1.5× 27 893
Megha Shettigar United States 3 325 0.7× 355 0.8× 174 0.8× 196 1.2× 72 0.6× 3 533

Countries citing papers authored by Suvi Parviainen

Since Specialization
Citations

This map shows the geographic impact of Suvi Parviainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi Parviainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi Parviainen more than expected).

Fields of papers citing papers by Suvi Parviainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suvi Parviainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi Parviainen. The network helps show where Suvi Parviainen may publish in the future.

Co-authorship network of co-authors of Suvi Parviainen

This figure shows the co-authorship network connecting the top 25 collaborators of Suvi Parviainen. A scholar is included among the top collaborators of Suvi Parviainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suvi Parviainen. Suvi Parviainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siurala, Mikko, Riikka Havunen, Dipongkor Saha, et al.. (2016). Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma. Molecular Therapy. 24(8). 1435–1443. 43 indexed citations
2.
Watanabe, Keisuke, Sònia Guedan, John Scholler, et al.. (2016). Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells. Blood. 128(22). 3360–3360. 1 indexed citations
3.
Siurala, Mikko, Markus Vähä‐Koskela, Riikka Havunen, et al.. (2016). Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. OncoImmunology. 5(5). e1136046–e1136046. 16 indexed citations
4.
Watanabe, Keisuke, John Scholler, Sònia Guedan, et al.. (2016). 515. Oncolytic Adenovirus Armed with Cytokines Enhances CAR-T Cell Efficacy in Pancreatic Tumor Model. Molecular Therapy. 24. S205–S206. 2 indexed citations
5.
Zafar, Sadia, Suvi Parviainen, Mikko Siurala, et al.. (2016). Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy. OncoImmunology. 6(2). e1265717–e1265717. 26 indexed citations
6.
Tähtinen, Siri, C Blattner, Markus Vähä‐Koskela, et al.. (2016). T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma. Journal of Immunotherapy. 39(9). 343–354. 22 indexed citations
7.
Parviainen, Suvi, Markus Vähä‐Koskela, Kilian Guse, et al.. (2015). Incomplete but Infectious Vaccinia Virions Are Produced in the Absence of Oncolysis in Feline SCCF1 Cells. PLoS ONE. 10(3). e0120496–e0120496. 4 indexed citations
8.
Tähtinen, Siri, Susanna Grönberg-Vähä-Koskela, Anna Kanerva, et al.. (2015). Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors. PLoS ONE. 10(6). e0131242–e0131242. 38 indexed citations
9.
Hemminki, Otto, Suvi Parviainen, Juuso Juhila, et al.. (2015). Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy. Oncotarget. 6(6). 4467–4481. 69 indexed citations
10.
Hirvinen, Mari, Maria Rajecki, Mika Kapanen, et al.. (2015). Immunological Effects of a Tumor Necrosis Factor Alpha–Armed Oncolytic Adenovirus. Human Gene Therapy. 26(3). 134–144. 47 indexed citations
11.
Parviainen, Suvi, Iulia Diaconu, Anja Kipar, et al.. (2014). GMCSF‐armed vaccinia virus induces an antitumor immune response. International Journal of Cancer. 136(5). 1065–1072. 30 indexed citations
12.
Knuuttila, Anna, Anja Kipar, Sari Pesonen, et al.. (2014). Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles. Molecular Therapy — Oncolytics. 1. 14002–14002. 12 indexed citations
13.
Knuuttila, Anna, Anja Kipar, Suvi Parviainen, et al.. (2014). Anti‐tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies. Veterinary and Comparative Oncology. 14(4). 395–408. 6 indexed citations
14.
Siurala, Mikko, Simona Bramante, Lotta Vassilev, et al.. (2014). Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma. International Journal of Cancer. 136(4). 945–954. 50 indexed citations
15.
Parviainen, Suvi, Iulia Diaconu, Mari Hirvinen, et al.. (2013). CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging. Gene Therapy. 21(2). 195–204. 34 indexed citations
16.
Bramante, Simona, Anniina Koski, Anja Kipar, et al.. (2013). Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans. International Journal of Cancer. 135(3). 720–730. 37 indexed citations
17.
Parviainen, Suvi, et al.. (2013). Mammal‐Derived Respiratory Lipocalin Allergens do not Exhibit Dendritic Cell‐Activating Capacity. Scandinavian Journal of Immunology. 77(3). 171–176. 9 indexed citations
18.
Diaconu, Iulia, Vincenzo Cerullo, Mari Hirvinen, et al.. (2012). Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus. Cancer Research. 72(9). 2327–2338. 136 indexed citations
19.
Kangasniemi, Lotta, Suvi Parviainen, Mika Jokinen, et al.. (2011). Effects of capsid‐modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer. International Journal of Cancer. 131(1). 253–263. 11 indexed citations
20.
Diaconu, Iulia, Sari Pesonen, Anna Kanerva, et al.. (2010). Calcium Gluconate in Phosphate Buffered Saline Increases Gene Delivery with Adenovirus Type 5. PLoS ONE. 5(9). e13103–e13103. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naomi De Silva Breakdown of academic impact, for papers by Shyambabu Chaurasiya Breakdown of academic impact, for papers by Margaret R. Duffy Breakdown of academic impact, for papers by Mari Hirvinen Breakdown of academic impact, for papers by Candice Willmon Breakdown of academic impact, for papers by Weizhou Hou Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Minna Oksanen Breakdown of academic impact, for papers by Timo Joensuu Breakdown of academic impact, for papers by Megha Shettigar
Rankless by CCL
2026